Medication info
CosKyex Tablet 5/100 mg

CosKyex Tablet 5/100 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›100mg / 1 tablet
Manufacturer / importer
SK Chemical Co., Ltd.
Appearance
Light pink oblong film-coated tablet
Packaging
Bottle packaging - 30 tablets/bottle
Approval status
Active

MFDS item code 201802435 · Approved 2018.06.12 · Insurance code 644704650

Summary

Main use
Treatment of essential hypertension; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine; however, switching directly to this medicine may be considered if blood pressure is not adequately controlled with monotherapy with either individual component, as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with combination therapy compared with monotherapy. This medicine is usually administered at 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients receiving dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: For patients aged 75 years and older, the recommended initial dose of losartan is 25 milligrams once daily; therefore, this medicine is not recommended for use as initial therapy.
Child dose
Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Ingredients

Manufacturer
SK Chemical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with amlodipine or losartan. It is also used as initial therapy when combination therapy is needed for patients with stage 2 hypertension to reach target blood pressure. In other words, it helps to effectively improve blood pressure control for hypertension treatment.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or losartan) before starting this medicine; however, switching directly to this medicine may be considered if blood pressure is not adequately controlled with monotherapy with either individual component, as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment goal with combination therapy compared with monotherapy. This medicine is usually administered at 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients receiving dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Elderly patients: For patients aged 75 years and older, the recommended initial dose of losartan is 25 milligrams once daily; therefore, this medicine is not recommended for use as initial therapy.

Child dose

Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.

Precautions

This drug can cause severe harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Hypotension may occur when first administered to patients with reduced blood volume, so this condition should be treated first, and it is recommended not to administer to patients who require specific dosage adjustments. Patients with allergic reactions to the main components of this drug or similar substances should not use it, and it should not be administered to patients with severely impaired liver or heart function. Dizziness may occur due to the blood pressure-lowering effect, so care should be taken when driving or operating dangerous machinery. Additionally, blood pressure variations may occur even after discontinuation, so careful adjustment is needed when administering other antihypertensive drugs. This drug is not recommended during breastfeeding, and its safety and effectiveness have not been established in children under 18 years of age. When used with other antihypertensive medications, the effect may be intensified, so caution is needed, and there may be changes in blood pressure or plasma drug concentration when combined with certain medications. Serious side effects include hypotension, decreased kidney function, hyperkalemia, and angioedema, so medical consultation should be sought immediately if unusual symptoms appear. In the case of overdose, severe hypotension or cardiac rhythm abnormalities may occur, requiring prompt emergency treatment, and the drug is not removed by blood dialysis. This drug should be stored out of reach of children, and changing the container for storage is not advisable as it may affect the quality.

Side effects

  • Hypotension
  • neonatal craniosynostosis
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb contraction
  • craniofacial malformation
  • pulmonary hypoplasia
  • prematurity
  • intrauterine growth restriction
Show 169 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • increased urination
  • fatigue
  • edema
  • vasculitis
  • tension increase
  • sensory loss
  • paresthesia
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin erythema
  • papular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle spasm
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • sinus disorders
  • pharyngitis
  • myalgia
  • edema
  • decreased appetite
  • dental pain
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper extremity pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decrease
  • decreased libido
  • memory impairment
  • migraine
  • hypersensitivity
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • nasal hemorrhage
  • rhinitis
  • respiratory congestion
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • sweating
  • erythematous skin disease
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste distortion
  • tinnitus
  • vision decrease
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver function abnormalities
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • elevated serum creatinine
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • shock
  • bradycardia
  • hypotension
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, avoid storing in excessively hot or cold places, and it is best to keep it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Light pink oblong film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.